These data clearly indicate that dsRNAs produced by parvovirus infections have structural characteristics and properties allowing their recognition by an RLR/MAVS antiviral pathway that eventually leads to IFN-β production. The gene discussed is MAVS; the disease is Parvoviridae infectious disease.